These findings indicate that the administration of Fasl in U-CH1 cell line is able to counteract the role of the anti-apoptotic form of Fas and induces the apoptotic pathway via Pro Caspase 8, suggesting that this pathway can be modulated in this tumor. The gene discussed is FAS; the disease is neoplasm.